Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7 billion in 2030. 2 Pain 1994 Apr;57(1):5-15. 3 Psychol Res Behav Manag.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

JUNE 30, 2021

According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Investors may want to take a closer look at the stock as it continues to collect complete reference records ahead of its launch late this year.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

DECEMBER 21, 2021

billion by 2030, growing at a CAGR of 8.4% from 2021 to 2030. Tests include on-site rapid antigen (results in under 20 minutes) and on-site RT-PCR sample collection (results in 24 hours). The second phase of cerVIA™ clinical trials in India is complete, with white paper submissions underway. billion (2020).

Research and Development 52

Research and Development Supply Chain Data Business 52